TPC inhibition or knockdown in mice was shown to increase the number of regulator T (Treg) cells in a transmembrane TNF/TNFR2 dependent manner, contributing to anti-inflammatory effects in a murine colitis model (He et al., 2020). The gene discussed is TNFRSF1B; the disease is colitis.